Company Legal Name
Latest Valuation
Founded Year
Headquarter
Reify Health develops software solutions that streamline clinical trial management for both research sites and pharmaceutical sponsors, focusing on recruitment and enrollment workflows. Founded in 2012 and headquartered in Baltimore, the company addresses critical inefficiencies in clinical research operations that often cause costly delays and budget overruns. Reify Health's platform enables better coordination between trial sites and sponsors, improving patient recruitment timelines and data management processes. The company serves the growing clinical research market, where digital transformation is increasingly essential for managing complex, multi-site studies and meeting regulatory requirements in pharmaceutical development.
Revenue & Revenue Growth Share
Revenue
Revenue Growth
Available in most regions; subject to local regulations.
Open to non-accredited investors with KYC/AML compliance. U.S. investors must meet SEC requirements.
$10 per token, enabling fractionalized access to Pre-IPO shares.
Mandatory identity (KYC) and proof of funds checks.
Variable, applied to investment amounts.
Charged on realized profits.
Tokens may be locked for 6–12 months; resale depends on secondary market liquidity.
Prices reflect past funding rounds, not guaranteed future value.
Biotech depends on regulatory approvals; fintech faces evolving digital asset rules.
Blockchain or custodian issues could delay transfers or verification.
Changing laws may affect tradability or taxation.





